EDGAR Filing Documents for 0001564590-19-022723

Form 8-K - Current report:

SEC Accession No. 0001564590-19-022723

Filing Date

2019-06-18

Accepted

2019-06-18 10:01:10

Documents

Period of Report

2019-06-18

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K INVESTOR PRESENTATION	atrs-8k_20190618.htm	8-K	36575
2	EX-99.1 COMPANY PRESENTATION SLIDES	atrs-ex991_6.htm	EX-99.1	19456
3	GRAPHIC	gvgzt3orq2bz000012.jpg	GRAPHIC	231699
4	GRAPHIC	gvgzt3orq2bz000014.jpg	GRAPHIC	222131
5	GRAPHIC	gvgzt3orq2bz000019.jpg	GRAPHIC	214356
6	GRAPHIC	gvgzt3orq2bz000023.jpg	GRAPHIC	191735
7	GRAPHIC	gvgzt3orq2bz000001.jpg	GRAPHIC	236099
8	GRAPHIC	gvgzt3orq2bz000024.jpg	GRAPHIC	234749
9	GRAPHIC	gvgzt3orq2bz000022.jpg	GRAPHIC	174398
10	GRAPHIC	gvgzt3orq2bz000009.jpg	GRAPHIC	161951
11	GRAPHIC	gvgzt3orq2bz000006.jpg	GRAPHIC	269238
12	GRAPHIC	gvgzt3orq2bz000008.jpg	GRAPHIC	267441
13	GRAPHIC	gvgzt3orq2bz000021.jpg	GRAPHIC	240759
14	GRAPHIC	gvgzt3orq2bz000005.jpg	GRAPHIC	272743
15	GRAPHIC	gvgzt3orq2bz000002.jpg	GRAPHIC	592688
16	GRAPHIC	gvgzt3orq2bz000016.jpg	GRAPHIC	152842
17	GRAPHIC	gvgzt3orq2bz000010.jpg	GRAPHIC	115780
18	GRAPHIC	gvgzt3orq2bz000013.jpg	GRAPHIC	212508
19	GRAPHIC	gvgzt3orq2bz000004.jpg	GRAPHIC	235291
20	GRAPHIC	gvgzt3orq2bz000017.jpg	GRAPHIC	360392
21	GRAPHIC	gvgzt3orq2bz000011.jpg	GRAPHIC	222663
22	GRAPHIC	gvgzt3orq2bz000020.jpg	GRAPHIC	211409
23	GRAPHIC	gvgzt3orq2bz000007.jpg	GRAPHIC	401392
24	GRAPHIC	gvgzt3orq2bz000018.jpg	GRAPHIC	215039
25	GRAPHIC	gvgzt3orq2bz000015.jpg	GRAPHIC	457143
26	GRAPHIC	gvgzt3orq2bz000003.jpg	GRAPHIC	339951
	Complete submission text file	0001564590-19-022723.txt		8645753

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)